Allurion Technologies
ALUR • NYSE
Allurion Technologies is a medical - devices company in the healthcare sector trading on NYSE, led by CEO Shantanu K. Gaur, with a market cap of $10.0M.
CEOShantanu K. Gaur
Next Earnings
Upcoming earnings announcement for Allurion Technologies
Date
Wednesday, May 13, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.36
Revenue Estimate
$3.1M
Earnings History
Past 8 earnings reports for Allurion Technologies
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 12, 2025 | Q3 2025 | -$1.18Est: -$1.74 | +32.2% | $2.7MEst: $2.1M | +29.7% |  10-Q |
| May 14, 2025 | Q1 2025 | $0.24Est: -$1.57 | +115.3% | $5.6MEst: $5.5M | +1.5% | 10-Q |
| Mar 26, 2025 | Q4 2024 | -$7.95Est: -$5.00 | -59.0% | $5.6MEst: $5.6M | -0.2% | — |
| Nov 13, 2024 | Q3 2024 | -$3.50Est: -$4.50 | +22.2% | $5.4MEst: $8.6M | -37.2% | — |
| Aug 13, 2024 | Q2 2024 | -$1.25Est: -$6.00 | +79.2% | $11.8MEst: $10.9M | +7.9% | — |
| May 14, 2024 | Q1 2024 | $2.75Est: -$7.50 | +136.7% | $9.4MEst: $9.2M | +2.0% | — |
| Mar 21, 2024 | Q4 2023 | -$10.00Est: -$12.75 | +21.6% | $8.2MEst: $8.2M | +0.4% | — |
| Nov 13, 2023 | Q3 2023 | -$13.50 | — | $18.2M | — | — |